News

A new variation of the CRISPR-Cas9 gene editing system, according to researchers from the Gladstone Institutes and University of California San Francisco (UCSF), enables the introduction of particularly long DNA sequences to specific locations in the genomes of cells...

According to complaints filed by Moderna, Pfizer and BioNTech's COVID-19 vaccine Comirnaty® violates patents the company filed between 2010 and 2016 that protect its core messenger RNA (mRNA) technology. Both the Regional Court of Düsseldorf in Germany and the United...

A recent study predicts that the size of the global formulation development outsourcing market will increase from its value of $35.1 billion in 2022 to $61.4 billion by 2030, growing at a CAGR of 7.2%. The researchers discovered that the...

The global pharmaceutical contract manufacturing market is anticipated to reach $130.2 billion by 2026 as a result of increasing demand for pharmaceuticals, particularly in developing economies. In 2020, the market was estimated to be worth $100 billion. Market research indicates...

A recent survey found that 86.9% of biopharmaceutical businesses outsource at least a portion of their operations, which has contributed to the $14 billion market for biopharmaceutical contract manufacturing. Over the next ten years, the investigators predict a very bright...

According to a study of the reasons behind warning letters sent by the US Food and Drug Administration Center for Drug Evaluation and Research and Center for Devices and Radiological Health between 2010 and 2020, poor current good manufacturing practise (cGMP) compliance and...

Due to challenges in export sales in the regulated markets and a large base effect in the home formulations sector, the Indian pharmaceutical industry is anticipated to achieve moderate revenue growth of 7-9% in the current fiscal. Because of ongoing...